TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06720987: A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 140 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$3,015,936

Rescue Site Savings

+$1,979,208

Unlock Full NCT06720987 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06720987 Rescue Dossier →